• 1
    Lamine F, Bouguerra R, Jabrane J, et al. Food intake and high density lipoprotein cholesterol levels changes during Ramadan fasting in healthy young subjects. Tunis Med 2006; 84: 647650.
  • 2
    Husain R, Duncan MT, Cheah SH, Ch'ng SL. Effect of fasting in Ramadan on tropical Asiatic Moslems. Br J Nutr 1987; 58: 4148.
  • 3
    Bahammam A. Does Ramadan fasting affect sleep? Int J Clin Pract 2006; 60: 16311637.
  • 4
    Lamri-Senhadji MY, El Kebir B, Belleville J, Bouchenak M. Assessment of dietary consumption and time-course of changes in serum lipids and lipoproteins before, during and after Ramadan in young Algerian adults. Singapore Med J 2009; 50: 288294.
  • 5
    Mafauzy M, Mohammed WB, Anum MY, Zulkifli A, Ruhani AH. A study of fasting diabetic patients during the month of Ramadan. Med J Malaysia 1990; 45: 1417: S.
  • 6
    Chamakhi S, Ftouhi B, Ben Rahmoune N, Ghorbal S, Ben Khalifa F. Influence of the fast of Ramadan on the balance glycaemic to diabetics. Medicographia 1991; 13: 2729: S1.
  • 7
    M'guil M, Ragala MA, El Guessabi L, et al. Is Ramadan fasting safe in type 2 diabetic patients in view of the lack of significant effect of fasting on clinical and biochemical parameters, blood pressure, and glycaemic control? Clin Exp Hypertens 2008; 30: 339357.
  • 8
    Khaled BM, Belbraouet S. Effect of Ramadan fasting on anthropometric parameters and food consumption in 276 type 2 diabetic obese women. Int J Diabetes Dev Ctries 2009; 29: 6268.
  • 9
    Reilly T, Waterhouse J. Altered sleep-wake cycles and food intake: the Ramadan model. Physiol Behav 2007; 90: 219228.
  • 10
    Yarahmadi S, Larijani B, Bastanhagh MH, et al. Metabolic and clinical effects of Ramadan fasting in patients with type II diabetes. J Coll Physicians Sur Pak 2003; 13: 329332.
  • 11
    Akanji AO, Mojiminiyi OA, Abdella N. Beneficial changes in serum apo A-1 and its ratio to apo B and HDL in stable hyperlipidaemic subjects after Ramadan fasting in Kuwait. Eur J Clin Nutr 2000; 54: 508513.
  • 12
    Al Suwaidi J, Bener A, Suliman A, et al. A population based study of Ramadan fasting and acute coronary syndromes. Heart 2004; 90: 695696.
  • 13
    Bener A, Hamad A, Fares A, Al-Sayed HM, Al-Suwaidi J. Is there any effect of Ramadan fasting on stroke incidence? Singapore Med J 2006; 47: 404408.
  • 14
    Belkhadir J, El Ghomari H, Klocker N, Mikou A, Naciri M, Sabri M. Muslims with non-insulin dependent diabetes fasting during Ramadan. Treatment with glibenclamide. Br Med J 1994; 307: 292295.
  • 15
    Sari R, Balci MK, Akbas SH, Avci B. The effects of diet, sulfonylurea, and repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan. Endocr Res 2004; 30: 169177.
  • 16
    Salti I, Be'nard E, Detournay B, et al. Results of the Epidemiology of Diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 2004; 27: 23062311.
  • 17
    Engel S, Katzef H, Musser B, et al. Hypoglycemia in sulfonylurea treated Muslim type 2 diabetic patients during Ramadan: a five country study. 70th Scientific Sessions American Diabetes Association 2010 Florida. Abstract 2207-PO.
  • 18
    Bakiner O, Ertorer ME, Bozkirli E, Tutuncu NB, Demirag NG. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan. Acta Diabetologia 2009; 46: 6365.
  • 19
    Cesur M, Corapcioglu D, Gursoy A, et al. A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting. Diabetes Res Clin Pract 2007; 75: 141147.
  • 20
    Muslim Spiritual Care Division in the NHS. Ramadan Health Factsheet 2009. A project of the Muslim Council in Partnership with the Department of Health. Available from Muslim Spiritual Care Provision in the NHS, PO box 57330, London E1 2WJ;
  • 21
    National Institute for Health and Clinical Excellence. Type 2 diabetes—newer agents (partial update of CG66). (Clinical Guideline 87) 2009. (Accessed 1 October 2010).
  • 22
    Garg S, Zisser H, Schwartz S, et al. Improvement in glycemic excursions with a transcutaneous, real-time, continuous glucose sensor: a randomized controlled trial. Diabetes Care 2006; 29: 4450.
  • 23
    Al-Arouj M, Bouguerra R, Buse J, et al. American Diabetes Association recommendations for management of diabetes during Ramadan. Diabetes Care 2005; 28: 23052311.
  • 24
    Hui E, Bravis V, Hassanein M, et al. Managing the diabetic patient during Ramadan. BMJ 2010; 340: c3053. DOI: 10.1136/bmj.c3053.
  • 25
    Beshyah SA. Fasting during the month of Ramadan for people with diabetes: medicine and Fiqh united at last. Ibnosina J Med Biomed Sci 2009; 1: 5860.
  • 26
    Norris SL, Engelgau MM, Narayan KM. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care 2001; 24: 561587.
  • 27
    Bravis V, Hui E, Salih S, Mehar S, Hassanein M, Devendra D. Ramadan education and awareness in diabetes programme for Muslims with type 2 diabetes who fast during Ramadan. Diabetes Med 2010; 27: 327331.
  • 28
    White M, Bush J, Kai J, Bhopal R, Rankin J. Quitting smoking and experience of smoking cessation interventions among UK Bangladeshi and Pakistani adults: the views of community members and health professionals. J Epidemiol Community Health 2006; 60: 405411.
  • 29
    Azar ST, Khairallah WG, Merheb MT, Zantout MS, Fliti F. Insulin therapy during Ramadan fast for patients with type 1 diabetes mellitus. J Med Liban 2008; 56: 46.
  • 30
    Kadiri A, Al-Nakhi A, El-Ghazali S, et al.Treatment of type 1 diabetes with insulin lispro during Ramadan. Diabetes Metab 2001; 27: 482486.
  • 31
    Benbarka MM, Khalil AB, Beshyah SA, Marjei S, Awad SA. Insulin pump therapy in Moslem patients with type 1 diabetes during Ramadan fasting: an observational report. Diabetes Technol Ther 2010; 12: 287290.
  • 32
    Glimperide in Ramadan (GLIRA) Study Group. The efficacy and safety of glimepiride in the management of type 2 diabetes in Muslim patients during Ramadan. Diabetes Care 2005; 28: 421422.
  • 33
    Vasan S, Thomas N, Bharani MD, et al. A double-blind, randomized, multicenter study evaluating the effects of pioglitazone in fasting Muslim subjects during Ramadan. Int J Diabetes Dev Ctries 2006; 26: 7076.
  • 34
    Beshyah SA, Benbarka MM, Sherif IH. Practical management of diabetes during Ramadan fast. Libyan J Med 2007; 2(4): 185189.
  • 35
    Karamat MA, Syed A, Hanif W. Review of diabetes management and guidelines during Ramadan. J R Soc Med 2010; 103: 139147.
  • 36
    Devendra D, Gohel B, Bravis V, Hui E, Salih S, Mehar S, Vildagliptin therapy and hypoglycaemia in Muslim type 2 diabetes patients during Ramadan. Int J Clin Pract 2009; 63: 14461450.
  • 37
    Mattoo V, Milicevic Z, Malone JK, et al. A comparison of insulin lispro Mix25 and human insulin 30/70 in the treatment of type 2 diabetes during Ramadan. Ramadan Study Group. Diabetes Res Clin Pract 2003; 59: 137143.
  • 38
    Hui E, Bravis V, Salih S, Hassanein M, Devendra D. Comparison of Humalog Mix 50 with human insulin Mix 30 in type 2 diabetes patients during Ramadan. Int J Clin Pract 2010; 64: 10951099.
  • 39
    Dikensoy E, Balat O, Cebesoy B, Ozkur A, Cicek H, Can G. Effect of fasting during Ramadan on fetal development and maternal health. J Obstet Gynaecol Res 2008; 34: 494498.
  • 40
    Chan F, Slater C, Syed AA. Religious fasts after bariatric surgery. BMJ 2010; 341: c3706.